- Home
- VFC vs LGND Comparison
VFC vs LGND Comparison
Compare VFC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VFC | LGND |
|---|---|---|
| Founded | 1899 | 1987 |
| Country | United States | United States |
| Employees | 26000 | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.0B |
| IPO Year | 1994 | 1997 |
Fundamental Metrics
Financial Performance| Metric | VFC | LGND |
|---|---|---|
| Price | $18.30 | $318.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 11 |
| Target Price | $19.86 | ★ $346.75 |
| AVG Volume (30 Days) | ★ 10.8M | 189.9K |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | 233.33 | ★ 2886.36 |
| EPS | 0.64 | ★ 1.63 |
| Revenue | ★ $10,488,556,000.00 | $141,102,000.00 |
| Revenue This Year | N/A | $8.13 |
| Revenue Next Year | $3.08 | $30.59 |
| P/E Ratio | ★ $28.68 | $193.72 |
| Revenue Growth | N/A | ★ 29.48 |
| 52 Week Low | $12.46 | $175.89 |
| 52 Week High | $22.27 | $326.63 |
Technical Indicators
Market Signals| Indicator | VFC | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 76.46 | 60.59 |
| Support Level | $17.95 | $277.97 |
| Resistance Level | $21.93 | $326.63 |
| Average True Range (ATR) | 0.69 | 10.34 |
| MACD | 0.10 | 1.27 |
| Stochastic Oscillator | 90.28 | 78.00 |
Price Performance
Historical ComparisonAbout VFC V.F. Corporation
VF designs, produces, and distributes apparel, footwear, and accessories with a focus on active and outdoor brands. Its portfolio of 10 labels includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and company-owned and partner-owned branded stores. Tracing its roots to 1899, VF has evolved into its present form through many brand acquisitions and divestitures.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.